PT100418A - Emulsoes parentericas especificas contendo derivados lipofilicos iodados e/ou bromados e derivados do fenantreno como agente emulsionante e sua utilizacao comoagentes de contraste de raios x - Google Patents
Emulsoes parentericas especificas contendo derivados lipofilicos iodados e/ou bromados e derivados do fenantreno como agente emulsionante e sua utilizacao comoagentes de contraste de raios xInfo
- Publication number
- PT100418A PT100418A PT100418A PT10041892A PT100418A PT 100418 A PT100418 A PT 100418A PT 100418 A PT100418 A PT 100418A PT 10041892 A PT10041892 A PT 10041892A PT 100418 A PT100418 A PT 100418A
- Authority
- PT
- Portugal
- Prior art keywords
- derivatives
- ray contrast
- pct
- derivative
- parenterical
- Prior art date
Links
- 239000003995 emulsifying agent Substances 0.000 title abstract 3
- 239000000839 emulsion Substances 0.000 abstract 5
- YQDSWSPIWVQKBC-UHFFFAOYSA-N 1h-cyclopenta[l]phenanthrene Chemical class C12=CC=CC=C2C2=CC=CC=C2C2=C1CC=C2 YQDSWSPIWVQKBC-UHFFFAOYSA-N 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 239000002872 contrast media Substances 0.000 abstract 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 abstract 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 abstract 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 abstract 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 abstract 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 abstract 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 abstract 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- HZYXFRGVBOPPNZ-KAFSRORWSA-N Sigmasterol Natural products CC[C@H](CC=C(C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C HZYXFRGVBOPPNZ-KAFSRORWSA-N 0.000 abstract 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 abstract 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 abstract 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 abstract 1
- 235000000431 campesterol Nutrition 0.000 abstract 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- -1 phytosterol Chemical compound 0.000 abstract 1
- 235000015500 sitosterol Nutrition 0.000 abstract 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 abstract 1
- 229950005143 sitosterol Drugs 0.000 abstract 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0461—Dispersions, colloids, emulsions or suspensions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Colloid Chemistry (AREA)
- Transceivers (AREA)
- Mobile Radio Communication Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9101214A SE470086B (sv) | 1991-04-23 | 1991-04-23 | Organspecifik emulsion |
Publications (2)
Publication Number | Publication Date |
---|---|
PT100418A true PT100418A (pt) | 1993-08-31 |
PT100418B PT100418B (pt) | 1999-08-31 |
Family
ID=20382533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT100418A PT100418B (pt) | 1991-04-23 | 1992-04-22 | Emulsoes parentericas especificas contendo derivados lipofilicos iodados e/ou bromados e derivados do fenantreno como agente emulsionante e sua utilizacao comoagentes de contraste de raios x |
Country Status (19)
Country | Link |
---|---|
US (1) | US5445811A (pt) |
EP (1) | EP0581842B1 (pt) |
JP (1) | JPH06506932A (pt) |
AT (1) | ATE181241T1 (pt) |
AU (1) | AU660974B2 (pt) |
CA (1) | CA2109094A1 (pt) |
DE (1) | DE69229441D1 (pt) |
DK (1) | DK0581842T3 (pt) |
ES (1) | ES2135405T3 (pt) |
FI (1) | FI934690L (pt) |
GR (1) | GR3031053T3 (pt) |
HU (1) | HU210577B (pt) |
IE (1) | IE921289A1 (pt) |
NO (1) | NO307449B1 (pt) |
NZ (1) | NZ242436A (pt) |
PT (1) | PT100418B (pt) |
SE (1) | SE470086B (pt) |
WO (1) | WO1992018169A1 (pt) |
ZA (1) | ZA922930B (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0605477B2 (en) * | 1991-09-17 | 2007-06-20 | GE Healthcare AS | Gaseous ultrasound contrast media |
MX9205298A (es) * | 1991-09-17 | 1993-05-01 | Steven Carl Quay | Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido |
US5409688A (en) * | 1991-09-17 | 1995-04-25 | Sonus Pharmaceuticals, Inc. | Gaseous ultrasound contrast media |
IL108416A (en) | 1993-01-25 | 1998-10-30 | Sonus Pharma Inc | Colloids with phase difference as contrast ultrasound agents |
US5558855A (en) * | 1993-01-25 | 1996-09-24 | Sonus Pharmaceuticals | Phase shift colloids as ultrasound contrast agents |
DE69427185T2 (de) * | 1993-01-25 | 2001-12-06 | Sonus Pharmaceutical, Inc. | Phase-Stift Kolloide zur Verwendung als Ultraschallkontrastmittel |
US5851510A (en) * | 1994-05-16 | 1998-12-22 | The Board Of Regents Of The University Of Michigan | Hepatocyte-selective oil-in-water emulsion |
US6423363B1 (en) * | 1997-08-22 | 2002-07-23 | Lipton, Division Of Conopco, Inc. | Aqueous dispersion |
ES2187201T3 (es) * | 1998-10-14 | 2003-05-16 | Cognis Deutschland Gmbh | Empleo de esteroles y de esterolesteres a nanoescala. |
US6274574B1 (en) | 1999-02-26 | 2001-08-14 | Kraft Foods, Inc. | Use of mesophase-stabilized compositions for delivery of cholesterol-reducing sterols and stanols in food products |
EP1499206A1 (en) * | 2002-04-10 | 2005-01-26 | Thomas P. Binder | Hydrothermically processed compositions containing phytosterols |
US7306819B2 (en) * | 2002-06-12 | 2007-12-11 | The Coca-Cola Company | Beverages containing plant sterols |
CA2534426A1 (en) * | 2003-08-08 | 2005-02-17 | Barnes-Jewish Hospital | Emulsion particles for imaging and therapy and methods of use thereof |
CA2545524C (en) * | 2003-10-24 | 2012-06-26 | The Coca-Cola Company | Process for preparing phytosterol dispersions for application in beverages |
CH712511B1 (de) * | 2006-09-18 | 2017-11-30 | Forim-X Ag C/O Prof Dr Med Richard Dirnhofer | Röntgenkontrastmittel für die postmortale, experimentelle und diagnostische Angiographie. |
ES2640456T3 (es) | 2006-09-18 | 2017-11-03 | Fumedica Ag | Agente de contraste de rayos X para la angiografía post mortem, experimental y diagnóstica |
FR3039767B1 (fr) | 2015-08-04 | 2017-09-08 | Guerbet Sa | Composition destinee a vectoriser un agent anticancereux |
US20220151886A1 (en) * | 2019-04-01 | 2022-05-19 | Conopco, Inc., D/B/A Unilever | Multiple emulsion comprising an oil continuous nanoemulsion and a method for using the same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB676738A (en) * | 1949-11-16 | 1952-07-30 | Bayer Ag | Parenterally administrable x-ray contrast agents |
GB721264A (en) * | 1952-10-13 | 1955-01-05 | Astra Apotekarnes Kem Fab | Improvements relating to contrast preparations for visualising the vascular system by x-ray |
US3356575A (en) * | 1965-04-13 | 1967-12-05 | Leo Ab | Autosterile injectable iodinated oil X-ray contrast medium |
US4192859A (en) * | 1978-09-29 | 1980-03-11 | E. R. Squibb & Sons, Inc. | Contrast media containing liposomes as carriers |
JPS6030652B2 (ja) * | 1979-05-07 | 1985-07-17 | 株式会社ミドリ十字 | 静脈注射用脂肪乳剤 |
US4404182A (en) * | 1980-01-08 | 1983-09-13 | The United States Of America As Represented By The Department Of Health And Human Services | Ethiodized oil emulsion for intravenous hepatography |
GB2156345B (en) * | 1984-03-30 | 1987-07-08 | Squibb & Sons Inc | Alkylamine salts of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents |
US5041278A (en) * | 1985-10-15 | 1991-08-20 | The Liposome Company, Inc. | Alpha tocopherol-based vesicles |
CH672733A5 (pt) * | 1987-05-22 | 1989-12-29 | Bracco Ind Chimica Spa | |
ES2054706T3 (es) * | 1987-06-11 | 1994-08-16 | Kabi Pharmacia Ab | Emulsion que contiene yodo. |
GB8900376D0 (en) * | 1989-01-09 | 1989-03-08 | Nycomed As | Iodinated esters |
AU642066B2 (en) * | 1991-01-25 | 1993-10-07 | Nanosystems L.L.C. | X-ray contrast compositions useful in medical imaging |
DE4111939A1 (de) * | 1991-04-12 | 1992-10-22 | Fresenius Ag | Parenteral verabreichbare, hitzesterilisierbare o/w-emulsion eines roentgenkontrastmittels |
SE9101709L (sv) * | 1991-06-03 | 1992-12-04 | Karlshamns Lipidteknik Ab | Lipidderivat som diagnostikum eller kontrastmedel |
US5318768A (en) * | 1992-05-01 | 1994-06-07 | Sterling Winthrop Inc. | Polymeric x-ray contrast compositions containing an organic crystalline x-ray contrast agent |
-
1991
- 1991-04-23 SE SE9101214A patent/SE470086B/sv not_active IP Right Cessation
-
1992
- 1992-04-22 US US08/137,061 patent/US5445811A/en not_active Expired - Fee Related
- 1992-04-22 JP JP4509031A patent/JPH06506932A/ja active Pending
- 1992-04-22 DE DE69229441T patent/DE69229441D1/de not_active Expired - Fee Related
- 1992-04-22 HU HU9303005A patent/HU210577B/hu not_active IP Right Cessation
- 1992-04-22 EP EP92909891A patent/EP0581842B1/en not_active Expired - Lifetime
- 1992-04-22 ES ES92909891T patent/ES2135405T3/es not_active Expired - Lifetime
- 1992-04-22 PT PT100418A patent/PT100418B/pt not_active IP Right Cessation
- 1992-04-22 DK DK92909891T patent/DK0581842T3/da active
- 1992-04-22 AT AT92909891T patent/ATE181241T1/de not_active IP Right Cessation
- 1992-04-22 WO PCT/SE1992/000261 patent/WO1992018169A1/en active IP Right Grant
- 1992-04-22 NZ NZ242436A patent/NZ242436A/en unknown
- 1992-04-22 CA CA002109094A patent/CA2109094A1/en not_active Abandoned
- 1992-04-22 AU AU16805/92A patent/AU660974B2/en not_active Ceased
- 1992-04-22 IE IE128992A patent/IE921289A1/en not_active Application Discontinuation
- 1992-04-23 ZA ZA922930A patent/ZA922930B/xx unknown
-
1993
- 1993-10-22 FI FI934690A patent/FI934690L/fi unknown
- 1993-10-22 NO NO933807A patent/NO307449B1/no not_active IP Right Cessation
-
1999
- 1999-08-23 GR GR990402131T patent/GR3031053T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE181241T1 (de) | 1999-07-15 |
JPH06506932A (ja) | 1994-08-04 |
DE69229441D1 (de) | 1999-07-22 |
WO1992018169A1 (en) | 1992-10-29 |
FI934690A0 (fi) | 1993-10-22 |
NO933807L (no) | 1993-10-22 |
SE9101214L (sv) | 1992-10-24 |
EP0581842B1 (en) | 1999-06-16 |
HU9303005D0 (en) | 1994-01-28 |
ZA922930B (en) | 1994-10-07 |
SE470086B (sv) | 1993-11-08 |
HU210577B (en) | 1995-05-29 |
EP0581842A1 (en) | 1994-02-09 |
GR3031053T3 (en) | 1999-12-31 |
NZ242436A (en) | 1994-03-25 |
IE921289A1 (en) | 1992-11-04 |
HUT65882A (en) | 1994-07-28 |
NO307449B1 (no) | 2000-04-10 |
US5445811A (en) | 1995-08-29 |
DK0581842T3 (da) | 1999-11-22 |
ES2135405T3 (es) | 1999-11-01 |
AU1680592A (en) | 1992-11-17 |
AU660974B2 (en) | 1995-07-13 |
CA2109094A1 (en) | 1992-10-24 |
SE9101214D0 (sv) | 1991-04-23 |
PT100418B (pt) | 1999-08-31 |
FI934690L (fi) | 1993-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT100418A (pt) | Emulsoes parentericas especificas contendo derivados lipofilicos iodados e/ou bromados e derivados do fenantreno como agente emulsionante e sua utilizacao comoagentes de contraste de raios x | |
AU643690B2 (en) | Injectable multi-phase emulsions | |
EP0782846A2 (en) | O/W/O type multiple emulsion and method of preparing the same | |
JPH08511013A (ja) | 乳化したペトロラタムを含有する皮膚保護組成物 | |
DE69020211D1 (de) | Kosmetische Doppelemulsionszusammensetzung. | |
GB2101907A (en) | Emulsifying agent and emulsified cosmetics | |
GB1229967A (pt) | ||
Weingarten et al. | Interactions of a non-ionic ABA copolymer surfactant with phospholipid monolayers: possible relevance to emulsion stabilization | |
Baekey et al. | Grapefruit pectin inhibits hypercholesterolemia and atherosclerosis in miniature swine | |
Lippold et al. | Comparison of the Wechsler Adult Intelligence Scale and the Wechsler Adult Intelligence Scale-Revised. | |
GB2002652A (en) | Process for the preparation of water-in-oil or oil-in-water emulsions containing polyethylene powder | |
EP0711169A4 (en) | Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods | |
Hayhurst, M., Braude, A. & Benatar | Anaphylactic-like reaction to hydrocortisone | |
Skanse et al. | The effect of corticotrophin and cortisone on serum lipids and lipoproteins | |
KR910002470A (ko) | 혈관 x선 촬영 보조제 | |
JP2930730B2 (ja) | 酸又は塩基加水分解を受ける活性成分を含有する緩衝されたエマルジョン組成物 | |
JPS56127308A (en) | Blood-coagulation factor 8 pharmaceutical | |
EP0715517A4 (en) | ESTRENSTEROIDS AS NEUROCHEMICAL INITIATORS OF A CHANGE IN HUMOTHALM FUNCTION IN PEOPLE AND RELATED PHARMACEUTICAL PREPARATIONS AND METHODS | |
Hendrickx et al. | Thymic atrophy and rebound enlargement following chemotherapy for testicular cancer | |
Bedrick et al. | Conjunctival Kaposi's sarcoma in a patient with myasthenia gravis | |
JPH1171228A (ja) | 油中水型乳化組成物 | |
Rubens et al. | Norethisterone acetate in the treatment of advanced breast cancer | |
JPH1129432A (ja) | 油中水型乳化組成物 | |
Koehler et al. | Iosefamate Meglumine: An lodinated Contrast Agent for Hepatic Computed Tomography Scanning | |
JPH10101520A (ja) | 皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19930331 |
|
FG3A | Patent granted, date of granting |
Effective date: 19990503 |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20011130 |